Home / Netherlands / Akzo Nobel N.V.
Akzo Nobel N.V.
Short position disclosed on September 24, 2026.
Evolution of the disclosed total
December 5, 2012 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Davidson Kempner Capital Management LP | 2.13% | new | September 23, 2026 | |
| Millennium International Management LP | 1.60% | new | September 10, 2026 | |
| BlackRock Advisors, LLC | 1.50% | +1.00 pt | September 24, 2026 | |
| O'Connor Alternative Investments, LLC | 1.29% | new | August 5, 2026 | |
| Millennium Capital Partners LLP | 1.12% | new | September 23, 2026 | |
| LMR Partners LLP | 1.10% | new | September 14, 2026 | |
| BlackRock Financial Management, Inc. | 0.61% | new | September 14, 2026 | |
| Pentwater Capital Management LP | 0.51% | new | August 28, 2026 |
In the United States AKZOF (OTC): 1,351,715 shares sold short on September 15, 2026.AKZOY (OTC): 201,937 shares sold short on September 15, 2026. FINRA names no fund.
On the other side: the funds that hold Akzo Nobel N.V. Titelia
Get the moves on Akzo Nobel N.V. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 4, 2024 | Marshall Wace LLP | 0.86% | |
| December 2, 2024 | Marshall Wace LLP | 0.99% | |
| November 27, 2024 | Marshall Wace LLP | 1.09% | |
| November 19, 2024 | AKO Capital LLP | 1.25% | |
| November 13, 2024 | Marshall Wace LLP | 1.10% | |
| November 6, 2024 | Marshall Wace LLP | 1.04% | |
| October 30, 2024 | AKO Capital LLP | 1.31% | |
| October 24, 2024 | Marshall Wace LLP | 0.91% | |
| October 23, 2024 | AKO Capital LLP | 1.22% | |
| October 16, 2024 | Marshall Wace LLP | 0.80% | |
| October 8, 2024 | AKO Capital LLP | 1.12% | |
| October 4, 2024 | AKO Capital LLP | 1.22% | |
| October 2, 2024 | Marshall Wace LLP | 0.72% | |
| September 27, 2024 | AKO Capital LLP | 1.38% | |
| September 26, 2024 | AKO Capital LLP | 1.48% | |
| September 25, 2024 | Marshall Wace LLP | 0.60% | |
| September 9, 2024 | Marshall Wace LLP | 0.50% | |
| August 30, 2024 | AKO Capital LLP | 1.51% | |
| August 5, 2024 | AKO Capital LLP | 1.48% | |
| July 24, 2024 | AKO Capital LLP | 1.53% | |
| July 23, 2024 | AKO Capital LLP | 1.45% | |
| June 24, 2024 | AKO Capital LLP | 1.31% | |
| June 12, 2024 | AKO Capital LLP | 1.27% | |
| June 6, 2024 | AKO Capital LLP | 1.10% | |
| June 5, 2024 | AKO Capital LLP | 1.00% | |
| April 24, 2024 | AKO Capital LLP | 0.92% | |
| April 15, 2024 | AKO Capital LLP | 0.80% | |
| April 10, 2024 | AKO Capital LLP | 0.72% | |
| March 25, 2024 | AKO Capital LLP | 0.64% | |
| March 19, 2024 | AKO Capital LLP | 0.51% | |
| February 13, 2024 | Marshall Wace LLP | 0.46% | |
| February 5, 2024 | Marshall Wace LLP | 0.52% | |
| January 2, 2024 | Marshall Wace LLP | 0.61% | |
| December 4, 2023 | Marshall Wace LLP | 0.50% | |
| March 31, 2023 | Marshall Wace LLP | 0.48% | |
| March 30, 2023 | Marshall Wace LLP | 0.58% | |
| March 29, 2023 | Marshall Wace LLP | 0.64% | |
| March 14, 2023 | Marshall Wace LLP | 0.70% | |
| March 10, 2023 | Marshall Wace LLP | 0.62% | |
| February 27, 2023 | Marshall Wace LLP | 0.51% | |
| February 14, 2023 | Marshall Wace LLP | 0.49% | |
| February 8, 2023 | Marshall Wace LLP | 0.58% | |
| February 3, 2023 | Marshall Wace LLP | 0.60% | |
| January 27, 2023 | Marshall Wace LLP | 0.52% | |
| June 18, 2020 | AKO Capital LLP | 0.48% | |
| June 4, 2020 | AKO Capital LLP | 0.50% | |
| April 19, 2017 | Citadel Europe LLP | 0.27% | |
| March 22, 2017 | Citadel Europe LLP | 0.59% | |
| March 2, 2017 | Citadel Europe LLP | 0.80% | |
| February 9, 2017 | Citadel Europe LLP | 0.71% |
Download 316 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Pharming Group N.V. 7.95% of the capital sold short
- Signify N.V. 7.52% of the capital sold short
- Imcd N.V. 4.65% of the capital sold short
- Fugro N.V. 4.20% of the capital sold short
- DSM-Firmenich AG 3.48% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- PostNL N.V. 2.55% of the capital sold short
- NSI N.V. 2.01% of the capital sold short
- Alfen N.V. 1.85% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Sligro Food Group N.V. 1.55% of the capital sold short
- Avantium N.V. 1.39% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Akzo Nobel N.V., source AFM, data as at September 24, 2026, https://www.quivad.com/action/akzo-nobel-n-v?page=6